Phase 3 trial results published in European Journal of Heart Failure identify key target population for Mesoblast allogeneic cell therapyNEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited ...
The goal of the neurologic examination is therefore to confirm the clinical suspicion of stroke and localize the ischemic territory involved. Treatments are then targeted toward the clinical findings.